Cheyne-Stokes Respiration CSR ; and neuro-hormonal derangement are primary determinants of the progression of chronic heart failure CHF ; , due to their prognostic capabilities. To date, however, the nature of this relationship has not been definitively described. To evaluate the relationship between CSR and neuro-hormonal activation, we studied 44 patients with CHF either of ischemic 25 ; or idiopathic 19 ; origin 34 M, age 672 years, BMI 271 kg m2 , 4 and 23 in III NYHA class, ejection fraction 342%, meanSEM ; . The assessment included 1 ; a complete neuro-hormonal profile that included plasma assays of renin activity PRA ; , as well as concentrations of aldosterone, catecholamines, atrial ANP ; and brain naturietic peptide BNP ; , and cortisol, and 2 ; a long-term ambulatory cardiorespiratory recording in free-living patients by means of a multi-sensor portable system LifeShirt , VivoMetrics, USA ; . Results of the neuro-hormonal profile were indicative of increased neurohormonal activation norepinephrine 64046 pg ml; ANP 12116 pg ml; BNP 26842pg ml; PRA 2.96.47 ng ml h, aldosterone 18625 pg ml, cortisol 1758 ng ml ; . Nighttime cardiorespiratory recordings revealed CSR in all patients, while 25 subjects exhibited daytime breathing abnormalities. Abnormal breathing time, as defined by presence of CSR or periodic breathing, was observed during 404% of the time for the total recordings. The apnea-hypopnea index was 202 events hr hypopneas 67 6; apneas 22326; mean maximum apnea duration 403 sec; mean minimum oxygen saturation 85.90.9 ; . The presence of CSR was significantly related to BNP r 0.57, p 0.001 ; , ANP r 0.52, p 0.001 ; and norepinephrine r 0.35, p 0.03 ; . These data indicate that breathing pattern abnormalities are frequent in patients with CHF and support an association between neuro-hormonal and ventilatory dysregulation, which may serve as a novel therapeutic target. MirixaTM tutorial The online training can be found at mirixa training or there is a link to the training on the Community Clinical website. Complete the CORE functions 1 6, Working a CCRxTM Welcome Case from A to Z, and Working a CCRxTM Formulary Review Case from A to Z. Complete the quiz found on the website while going through the training videos. The student will hand in the quiz to the College faculty. OutcomesTM tutorial The online training can be found at getoutcomes under the Pharmacists tab. Upon completion of the training, the student will be sent an email. A copy of this email will be given to the College faculty and isoniazid.
The government has given me the marijuana to smoke.
I had a friend also look at me while riding to see if i sit straight on the saddle and he said i did; if anything just slightly to the left and ampicillin.
Even in the most ideal circumstances, only about 40% of heart attacks acn be prevented. With at least one other antituberculous drug. Selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in vitro susceptibility studies. In patients who have not received previous antituberculous therapy, ie, initial treatment, the most frequently used regimens have been the following: MYAMBUTOL plus isoniazid MYAMBUTOL plus isoniazid plus streptomycin. In patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. Consequently, in such retreatment patients, MYAMBUTOL should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. Antituberculous drugs used with MYAMBUTOL have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. Isoniazid, aminosalicylic acid, and streptomycin have also been used in multiple drug regimens. Alternating drug regimens have also been utilized. CONTRAINDICATIONS MYAMBUTOL is contraindicated in patients who are known to be hypersensitive to this drug. It is also contraindicated in patients with known optic neuritis unless clinical judgement determines that it may be used. PRECAUTIONS The effects of combinations of MYAMBUTOL ethambutol hydrochloride with other antituberculous drugs on the fetus is not known. While administration of this drug to pregnant human patients has produced no detectable effect upon the fetus, the possible teratogenic potential in women capable of bearing children should be weighed carefully against the benefits of therapy. There are published reports of five women who received the drug during pregnancy without apparent adverse effect upon the fetus. MYAMBUTOL is not recommended for use in pediatric patients under thirteen years of age since safe conditions for use have not been established. Patients with decreased renal function need the dosage reduced as determined by serum levels of MYAMBUTOL, since the main path of excretion of this drug is by the kidneys. Because this drug may have adverse effects on vision, physical examination should include ophthalmoscopy, finger perimetry and testing of color discrimination. In patients with visual defects such as cataracts, recurrent inflammatory conditions of the eye, optic neuritis, and diabetic retinopathy, the evaluation of changes in visual acuity is more difficult, and care should be taken to be sure the variations in vision are not due to the underlying disease conditions. In such patients, consideration should be given to relationship between benefits expected and possible visual deterioration since evaluation of visual changes is difficult. For recommended procedures, see next paragraphs under Adverse Reactions. ; As with any potent drug, periodic assessment of organ system functions, including renal, hepatic, and hematopoietic, should be made during long-term therapy and cleocin. Active Infection Treatment is always with multiple drugs for 612 months on average and only initiated by a physician. The optimal initial regimen is three or four drugs, including INH, rifampin Rifadin ; , pyrazinamide Tebrazid ; , ethambutol Myzmbutol ; and streptomycin Table 6 ; . If drug resistance is a possibility, a four-drug regimen should be considered. In addition to the antituberculous drugs, the client may also be given vitamin B6 especially in the presence of alcoholism, diabetes mellitus or pregnancy, or if there is a concern about nutritional status ; , although this is optional. Start and stop dates for each Period I: 12-05-2005 phase of the clinical study Period II: 19-05-2005 Investigational Products Ethambutol Hydrochloride 400 mg, tablets Manufactured by : Macleods Pharmaceutical Ltd., India Batch number : EG-402 Myamutol tablet containing Ethambutol dihydrochloride 400 mg ; Manufacturer bz : Reimser Arzneimittel AG Wyeth Lederle, Germany ; . Batch number N : 208770 Dr. Nathrao Latpate, MD Macleods Pharmaceuticals Ltd and minocin.
After less than two hours using hydroxypropylcellulose which had had been exposed to ultrasonic degradation. This more rapid reduction in drug particle size could be explained by a greater milling efficiency due to a lower viscosity or by lower molecular weight polymers having a faster ability to diffuse to the newly generated drug particle surfaces. partments within the cell indicating endocytosis, potentially bypassing the P-glycoprotein pump. The conjugates were similar in cytotoxicity and showed an increase in dose tolerance in comparison with doxorubicin. Carlsson et al AstraZeneca R&D and Uppsala University, Sweden ; verify enzymemediated degradation in intestinal fluid of a model drug and compare the degradation in human intestinal fluid and dog intestinal fluid. The parent drug, an ester, and the expected degradation product, the corresponding acid, are determined by HPLC. Enzyme-mediated degradation in the intestine can be determined by in vitro testing in real intestinal fluids, and should thus be a useful tool in early drug development. The dog seems to be a reasonably good model for man, although the degradation capacity seems to be somewhat higher possibly due to a higher enzyme concentration. croparticles as a sustained delivery system for oesophageal delivery.The retention of alginate microparticles on the oesophageal tissue is significantly higher than that of an equivalent alginate solution. For both formulations, the greatest loss is observed in the first 20 minutes, although the solution continues to show greater loss thereafter. It may be possible to develop an alginate microparticulate formulation that is retained on the surface of the oesophagus for prolonged periods, thus enabling the incorporated or attached drug to be adsorbed onto or absorbed into the oesophageal tissue.

As important as it is for us to avoid calcium thieves, there are several additional nutritional components to bone health that must be consumed in order to prevent or reverse osteoporosis and tetracycline. ANTIRETROVIRALS NRTIs- abacavir Ziagen ; , abacavir lamivudine Epzicom ; , abacavir lamivudine zidovudine Trizivir ; , didanosine ddI, Videx, Videx EC ; , emtricitabine Emtriva ; , lamivudine Epivir, 3TC ; , lamivudine zidovudine Combivir ; , stavudine d4T, Zerit ; , tenofovir Viread ; , tenofovir emtricitabine Truvada ; , zalcitabine ddC, Hivid ; , zidovudine AZT, Retrovir ; . PIs- amprenavir Agenerase ; , atazanavir Reyataz ; , fosamprenavir Lexiva ; , indinavir Crixivan ; , lopinavir ritonavir Kaletra ; , nelfinavir Viracept ; , ritonavir Norvir ; , saquinavir Invirase ; , tipranavir Aptivus ; . NNRTIs- delavirdine Rescriptor ; , efavirenz Sustiva ; , nevirapine Viramune ; . Entry Inhibitors- enfuvirtide Fuzeon ; . OI DRUGS PHS "A1 OI"s- acyclovir Zovirax ; , amphotericin B, azithromycin Zithromax ; , clarithromycin Biaxin ; , clindamycin, fluconazole Diflucan ; , foscarnet Foscavir ; , ganciclovir, itraconazole Sporonox ; , leucovorin, pentamidine IV, NebuPent ; , prednisone, pyrimethamine Daraprim ; , rifabutin Mycobutin ; , rifampim, sulfadiazine, TMP SMX Bactrim ; valacyclovir Valtrex ; , valganciclovir Valcyte ; . Other OIs- adefovir dipivoxil Hepsera ; , atovaquone Mepron ; , dapsone, erythropoietin Procrit ; , ethambutol Myamgutol ; , filgrastim Neupogen ; , metronidazole Flagyl ; , nystatin, paromomycin Humatin ; , primaquine, promethazine HCI Phenergan ; , TREATMENTS FOR METABOLIC DISORDERS Cardiac- hydrochlorothiazide, losartan, lotensin, quinapril Accupril ; . Hyperlipidemia- atorvastatin Lipitor ; , gemfibrozil Lopid ; , Prevastatin Pravachol ; . Diabetes- pioglitazone hydrochloride Actos ; , rosiglitazone maleate Avandia ; , metformin Glocophage ; , glipizide Glucotrol ; . Wasting- megestrol acetate Megace ; . ALL OTHERS albuterol, Aldactone ; , amitriptyline Elavil ; , betamethasone topical, bupropion Wellbutrin ; , ceftraxione Rocephin ; , cosyntropin Cortrosyn ; , fluticasone propionate Flonase ; , gabapentin Neurontin ; , hydrocortisone, ibuprofen, lansoprazole Prevacid ; , metoprolol Lopressor; Toprol XL ; , nasacort, Paroxetine Paxil ; , peginterferon Alfa-2a & ribavirin Pegasys Copegus ; * , pegylated interferon Alfa-2b & ribavirin Peg Intron Rebetol ; * , phenytoin Dilantin ; , rofecoxib Vioxx ; , sertraline Zoloft ; , vancomycin, venlaxafine Effexor ; . Removed in 2005- fenofibrate Tricor ; , flagyl, hydroxyurea Hydrea ; , rifadin. Can TB be treated? TB disease can be treated and cured with medication. TB treatment starts with at least four drugs, but the number of drugs may be reduced after two months. People with HIV may have to take the drugs longer than people without HIV. It is important to take all of your medication until the doctor says you are cured. Skipping medications or stopping because you feel better may cause the TB to become contagious again. Some of the more common drugs to cure TB include: Isoniazid INH ; , Rifampin Rifadin ; , Rifabutin Mucobutin ; , Ethambutol Mhambutol ; , and Pyrazinamide PZA ; . Pneumocystis Carinii Pneumonia PCP ; What is PCP? Pneumonia is an illness that causes inflammation of the lungs. There are many different germs that can cause pneumonia. The germ that causes PCP is called Pneumocystis carinii. Most of us are infected with the germ that causes PCP in childhood, since it is everywhere in the environment. A healthy immune system is enough to keep the germ from making us sick. Only when our immune system becomes very weak can PCP cause illness. What are the symptoms of PCP? In people with HIV it is common for symptoms to develop slowly, you may not realize something is wrong until you are quite sick. Some of the common symptoms include fever, chest tightness, shortness of breath, lack of energy, dry cough and weight loss. Weakness may be the only symptom if you are taking medications to prevent PCP. Can PCP be prevented? PCP is almost entirely preventable. If you are at risk for PCP it is strongly recommended you take medications to prevent PCP. People who are at risk include those with a CD4 count below 200; people with oral thrush or unexplained fevers lasting more than 2 weeks regardless of CD4 count people who have had PCP before. Ask your doctor if you should be on this medication. Can PCP be treated? The earlier PCP is treated the sooner you will feel better and the less likelihood of complications. PCP is treated either orally or intravenous IV ; medications depending on the severity of the PCP. Some of the most common medications include TMP SMX bactrim ; , Dapsone, Clindamycin Primaquine and Atovaquone Mepron and minocycline. BrandName Muri-Lube Murine Ear Drops Murine Tears Murine Tears Plus Muro 128 Muro 128 Muro 128 Murocel Murocoll 2 Muscle Rub Muse Muse Muse Muse Mustargen Mutamycin Mutamycin Mutamycin M-Vit Myadec Myambutol Myambutol My-A-Multi Mycamine Mycamine Mycasone Mycelex Mycelex Mycelex OTC Mycelex OTC Mycelex Troche Mycelex Twin Pak Mycelex-3 Mycelex-7 Mycelex-7 Mycelex-G Myci Spray Mycifradin Myciguent Myciguent Mycinette Sore Throat Spray Mycitracin Plus Pain Reliever Mycitracin Plus Pain Reliever obsolete ; Mycitracin Triple Antibiotic Myco Biotic II Myco Biotic II Mycobutin Mycogen II DrugName mineral oil carbamide peroxide otic ocular lubricant povidone-tetrahydrozoline ophthalmic sodium chloride, hypertonic, ophthalmic sodium chloride, hypertonic, ophthalmic sodium chloride, hypertonic, ophthalmic ocular lubricant phenylephrine-scopolamine ophthalmic methyl salicylate topical alprostadil alprostadil alprostadil alprostadil mechlorethamine mitomycin mitomycin mitomycin multivitamin with minerals multivitamin with minerals ethambutol ethambutol multivitamin with minerals micafungin micafungin nystatin-triamcinolone topical clotrimazole topical clotrimazole topical clotrimazole topical clotrimazole topical clotrimazole clotrimazole topical butoconazole topical clotrimazole topical clotrimazole topical clotrimazole topical phenylephrine-pyrilamine nasal neomycin neomycin topical neomycin topical phenol topical bacitracin neomycin polymyxin B pramoxine top bacitracin lidocaine neomycin polymyxin B top bacitracin neomycin polymyxin B topical nystatin-triamcinolone topical nystatin-triamcinolone topical rifabutin nystatin-triamcinolone topical Strength 100% 6.5% preserved 0.6%-0.05% 2% 5% preserved 10%-0.3% 1000 mcg 125 mcg 250 mcg 500 mcg 10 mg 20 mg 40 mg 5 mg Multiple Vitamins with Minerals Therapeutic Multiple Vitamins with Minerals 100 mg 400 mg Therapeutic Multiple Vitamins with Minerals 100 mg 50 mg 100000 units g-0.1% 1% mg 100 mg-1% 2% 1% 100 mg 500 mg 0.25%-0.15% 125 mg 5 ml 0.5% 1.4% units-3.5 mg-10000 units-10 mg g 400 units-50 mg-3.5 mg-5000 units g 400 units-3.5 mg-5000 units g 100000 units g-0.1% 100000 units g-0.1% 150 mg 100000 units g-0.1% Route oral otic ophthalmic ophthalmic ophthalmic ophthalmic ophthalmic ophthalmic ophthalmic topical transurethral transurethral transurethral transurethral injectable intravenous intravenous intravenous oral oral oral oral oral intravenous intravenous topical topical topical topical vaginal oral vaginal vaginal vaginal vaginal vaginal nasal oral topical topical topical topical topical topical topical topical oral topical Form liquid solution solution drops solution ointment solution solution solution cream suppository suppository suppository suppository powder for injection powder for injection powder for injection powder for injection tablet tablet tablet tablet tablet powder for injection powder for injection cream cream solution solution cream with applicator lozenge kit cream cream with applicator tablet tablet spray solution cream ointment spray ointment ointment ointment cream ointment capsule cream MMDC 3885 4218 5681. ANTIRETROVIRALS NRTIs- abacavir Ziagen ; , abacavir lamivudine Epzicom ; , abacavir lamivudine zidovudine Trizivir ; , didanosine ddI, Videx ; , emtricitabine Emtriva ; , lamivudine Epivir, 3TC ; , lamivudine zidovudine Combivir ; , stavudine d4T, Zerit ; , tenofovir Viread ; , tenofovir emtricitabine Truvada ; , zalcitabine ddC, Hivid ; , zidovudine AZT, Retrovir ; . PIs- amprenavir Agenerase ; , atazanavir Reyataz ; , fos-amprenavir calcium Lexiva ; , indinavir Crixivan ; , lopinavir ritonavir Kaletra ; , nelfinavir Viracept ; , ritonavir Norvir ; , saquinavir Invirase ; . NNRTIsdelavirdine Rescriptor ; , efavirenz Sustiva ; , nevirapine Viramune ; . Entry Inhibitors- enfuvertide Fuzeon ; . OI DRUGS PHS "A1 OI"s- acyclovir Zovirax ; , amphotericin B Fungizone ; , azithromycin Zithromax ; , clarithromycin Biaxin ; , clindamycin Cleocin ; , famciclovir Famvir ; , fluconazole Diflucan ; , foscarnet Foscavir ; , ganciclovir Cytovene ; , isoniazid INH ; , itraconazole Sporanox ; , leucovorin, pentamidine NebuPent, Pentam ; , probenecid, pyrazinamide PZA ; , pyrimethamine Daraprim ; , ribavirin * , rifabutin Mycobutin ; , rifampin Rifadin ; , sulfadiazine, TMP SMX Septra ; , valacyclovir Valtrex ; , valganciclovir Valcyte ; . Other OIs- amikacin Amikin ; , amoxicillin Trimox ; , amoxicillin clavulanate Augmentin ; , atovaquone Mepron ; , capreomycin Capastat ; , ceftriaxone Rocephin ; , ciprofloxacin Cipro ; , clofaximine Lamprene ; , clotrimazole Lotrimin, Mycelex ; , cycloserine Sermycin ; , dapsone, doxycycline Vibramycin ; , econazole nitrate Spetazole ; , epoetin alfa Procrit ; , erythromycin base PCE ; , ethambutol Myambutol ; , ethionamide Trecator SC ; , filgrastin Neupogen ; , interferon alfa-2a & alfa2b * , IVIG Gamimune-N, Gammagard ; , kanamycin Kantrex ; , ketoconazole Nizoral ; , metronidazole Flagyl ; , nystatin Mycostatin ; , ofloxacin Floxin ; , para aminosalicyclic acid Paser ; , peg-interferon alfa-2a * , peg-interferon alfa-2b & ribavirin Peg-Intron Rebetol ; * , penicillin G benzathine Bicillin LA ; , triple sulfa. TREATMENTS FOR METABOLIC DISORDERS Wasting- megestrol acetate Megace ; . ALL OTHERS acetaminophen Tylenol ; , albuterol Proventil ; , amytriptyline Elavil ; , antacids Mylanta, Maalox ; , betamethasone dipropionate Diprolene ; , betamethasone clotrimazole cream Lotrisone ; , capsaicin Zostrix ; , cefadroxil Duricef ; , cetirizine Zyrtec ; , clindamycin vaginal cream Cleocin ; , clotrimazole vaginal cream Gyne-Lotrimin ; , cold cream generic ; , controlled-release iron with vitamin C & B-complex, diphenhydramine Benadryl ; , fenofibrate, flurbiprofen Ansaid ; , fluoxetine Prozac ; , guaifenesin oxtriphyline Brondelate ; , guaifenesin phenylephrine Albatussin SR, NN ; , hydrocortisone cream, hydroxyzine pamoate, imiquimod Aldara ; , Ionil-T shampoo, ketaconazole shampoo, Ku-Zyme amylase, cellullase, lipase, protease ; , lanzoprazole Prevacid ; , lidocaine HCI Emla Cream, Xylocaine ; , lindane shampoo, lotion, loperamide Imodium ; , loratidine Claritin ; , metronidazole vaginal cream Metrogel ; , mometasone Elocon ; , multivitamins, piridoxine, podophyllin, pseudoephedrine triprolidine Actifed ; , ranitidine Zantac ; , sertraline HCI Zoloft ; , spectomycin Trobicin ; , sterile water, sucralfate Carafate ; , syrup vehicle, terconazole vaginal cream Terazol ; , triamicinolone Kenalog ; , trichloroacetic acid, triple antibiotic ointment, vitamins and minerals Albafort, Alba-Lybe, ferrous sulfate, folic acid, Iberet folic, Nervidox, Piridoxina, Tia-Doce, Unicap and doxycycline.

The effectiveness of anti-TB treatment is quite good, regardless of HIV infection. However, it is vital that people take the full course of drugs in order to kill all the TB and to prevent the development of anti-TB drug resistance or recurrence of active TB disease. People on anti-TB drugs are generally encouraged to see their doctors at least once a month and maybe more often at the start of treatment. This is to check whether the drugs are working, to identify adherence problems problems with taking the drugs as prescribed ; , and to monitor for side effects or reactions. Treating TB in the lungs and other organs is the same and usually lasts for six months, although widespread TB may require taking anti-TB therapies for a longer period of time. Treating TB in the brain meninges ; , bones or joints might require at least nine months of therapy. If anti-TB treatment doses are missed for any reason, longer courses of treatment are likely necessary. Also, people who don't respond quickly to the normal course of therapy might need to continue on anti-TB for nine months or longer. Symptoms of active TB disease usually ease off 34 weeks after starting anti-TB treatment. When a person has had three negative smear tests, he or she is considered to be non-infectious, or not likely to be able to infect others with TB. This usually occurs 23 months after starting anti-TB treatment. The first line treatment for TB disease is a combination of four drugs that includes isoniazid Nydrazid ; 300mg day, rifampin Rifadin, Rimactane ; 450600mg day, pyrazinamide Tebrazid ; 2030mg kg day, and ethambutol Myambutol ; 1525mg kg day or streptomycin sulfate 15mg kg day. These five drugs are given and resistance testing is performed. If the resistance test shows that the TB can be killed by isoniazid and rifampin, then the ethambutol or streptomycin can be stopped. The US Public Health guidelines recommend that people with HIV taking isoniazid also take pyridoxine Vitamin B6 ; because they are at higher risk for developing peripheral neuropathy. We believe that equity-based compensation is the most effective means of aligning the compensation provided to executives with stockholder interests by creating economic incentive for the creation of long-term stockholder 1 ; see column “ g” of the “ summary compensation table” on page 32 for the specific bonus awarded to each named executive. For most transplant recipients, gi complications, although common, will resolve or can be controlled with medical treatment, life style changes, and preventative care.

Sources include dairy products make low fat choices ; , green leafy vegetables, broccoli, collard and turnip greens, and kale, as well as canned salmon and sardines with bones, firm tofu, dried figs, chickpeas, and white and pinto beans. Dose and relative drug toxicity of halofuginone when administered twice weekly for 4 consecutive weeks. Thirty male Fischer 344 rats received intravenous doses of 0, 0.75, 1.5, 3.0, or 4.0 mg kg halofuginone. A high incidence of drug-related mortality occurred in rats at the two highest dose levels. Dosing was suspended following the third dose administration for the 3.5 and 4.0 mg kg groups due to the moribund condition of the animals. A drug related effect at 3.5 and 4.0 mg kg was noted by marked clinical observations lethargy, hunched posture, red eye nasal discharge, unresponsive, alopecia, thin appearance, soiled anal region and urine stain ; and group mean body weight decreases. Changes in hematology and serum chemistry parameters were also noted. Histological review of the bone marrow and spleens of all 3.5 and 4.0 mg kg rats indicated toxicologically significant hematopoietic depression. Several serum chemistry parameters were also decreased in the 3.5 and 4.0 mg kg groups. Decreases in TP and ALB were attributed to gastrointestinal toxicity diarrhea ; , which corresponded to intestinal lesions seen microscopically necrosis, edema, dilation, hyperplasia, and or ulcers ; . Elevated BUN and CREA were noted in many unscheduled-death rats, related to dehydration secondary to the reported diarrhea. Rats in the 3.0 mg kg group and lower had few or no clinical signs non-drug related ; . Based on these findings, doses of halofuginone at 3.5 mg kg and higher produced high mortality, bone marrow depletion and gastrointestinal toxicity. Findings at doses of 1.5 and 3.0 mg kg were not as severe and reversible. The maximally tolerated dose in rats appears to be between 3.0mg kg and 3.5mg kg and buy isoniazid!

The concept of therapeutic equivalence, as used in developing the List, applies only to drug products containing the same active ingredient s ; and does not encompass a comparison of different therapeutic agents used for the same condition e.g., propoxyphene hydrochloride vs. pentazocine hydrochloride for pain treatment. 4. If you are employed for pay, have you missed any days of work BECAUSE OF YOUR HEALTH in the PAST 6 Yes No MONTHS January through June ; ? If Yes, how many days?.